Quest Diagnostics
542 hedge funds and large institutions have $9.73B invested in Quest Diagnostics in 2015 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 169 increasing their positions, 220 reducing their positions, and 55 closing their positions.
94% more call options, than puts
Call options by funds: $49M | Put options by funds: $25.3M
9% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 55
2% less funds holding
Funds holding: 553 → 542 (-11)
3.11% less ownership
Funds ownership: 96.72% → 93.62% (-3.1%)
9% less capital invested
Capital invested by funds: $10.7B → $9.73B (-$951M)
21% less funds holding in top 10
Funds holding in top 10: 14 → 11 (-3)
23% less repeat investments, than reductions
Existing positions increased: 169 | Existing positions reduced: 220
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$131M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$54.5M |
| 3 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
+$48.4M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$47.9M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$36.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$192M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$70.8M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$65.1M |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$50.8M |
| 5 |
AI
Analytic Investors
Los Angeles,
California
|
-$49.2M |
DGX Hedge Fund Activity: Q2 2015 in Review
542 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2015, worth a combined $9.73B — down 8.9% from $10.7B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of DGX and 50 opened new positions — a net loss of 5 holders — while 220 trimmed existing stakes and 169 added.
The largest buyer was Schroder Investment Management Group, adding an estimated $131M. The largest seller was T. Rowe Price Associates, cutting an estimated $192M.
- 542 institutional investors held Quest Diagnostics (DGX) as of Q2 2015, down from 553 in Q1 2015.
- Funds reported $9.73B of Quest Diagnostics stock for Q2 2015, down 8.9% quarter-over-quarter.
- 50 funds opened new Quest Diagnostics positions in Q2 2015 and 55 closed out, a net change of -5 holders.
- The largest Quest Diagnostics buyer in Q2 2015 was Schroder Investment Management Group, an estimated $131M added.
- The largest Quest Diagnostics seller in Q2 2015 was T. Rowe Price Associates, an estimated $192M sold.
Based on aggregated 13F filings for Q2 2015.